CTRI/2021/08/035884尚未招募4 期
A prospective, randomized, triple-blind comparative study of ropivacaine with bupivacaine plus lidocaine mixtures used in peribulbar blocks for cataract surgery - RVB
Gayatri vidya parishad Institute of health care and medical technology0 个研究点目标入组 0 人开始时间: 待定最近更新:
试验速览
- 阶段
- 4 期
- 状态
- 尚未招募
- 发起方
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
入选标准
- •Inclusion criteria for our study consist of both male and female
- •patients with an age range between 40 and 80 years and are of
- •American Society of Anesthesiologists (ASA) physical status grades
- •I and II attending our medical college hospital for elective cataract
排除标准
- •The exclusion criteria for our study include patients with known
- •allergy to study drugs, those refusing the regional block, those on
- •anticoagulant therapy, high myopia (axial length of eyeball > 28 mm),
- •previous ophthalmic surgery such as buckling surgery, glaucoma,
- •posterior staphyloma, ocular infection, orbital anomaly, mental
- •retardation, uncontrolled hypertension & diabetes mellitus, and
- •chronic obstructive pulmonary disease.
研究者
相似试验
尚未招募
4 期
Ropivacaine-dexmedetomidine versus ropivacaine alone in peribulbar blocksCTRI/2020/03/023951Gayatri vidya parishad Institute of health care and medical technology
已完成
不适用
A clinical study to assess the safety and effectiveness of collagen-containing test products in healthy adult Human subjectsCTRI/2022/11/047566Bright LifeCare Private Limited56
进行中（未招募）
1 期
A safety and immune study of 2 types of GlaxoSmithKline’s varicella vaccines given as a 2-doses course to healthy children 12-23 months of ageEUCTR2013-003535-30-GBGlaxoSmithKline Biologicals1,220
进行中（未招募）
1 期
A safety and immune study of 2 types of GlaxoSmithKline’s varicella vaccines given as a 2-doses course to healthy children 12-23 months of ageEUCTR2013-003535-30-DEGlaxoSmithKline Biologicals1,220
进行中（未招募）
1 期
A safety and immune study of 2 types of GlaxoSmithKline’s varicella vaccines given as a 2-doses course to healthy children 12-23 months of ageVaccinating Healthy volunteers (Active immunization against varicella virus disease of healthy children in their second year of life).MedDRA version: 18.1Level: PTClassification code 10069613Term: Varicella immunisationSystem Organ Class: 10042613 - Surgical and medical proceduresMedDRA version: 18.0Level: LLTClassification code 10069628Term: Varicella immunizationSystem Organ Class: 10042613 - Surgical and medical proceduresMedDRA version: 18.0Level: LLTClassification code 10063315Term: Varicella zoster virus DNA test positiveSystem Organ Class: 100000004848MedDRA version: 18.0Level: LLTClassification code 10046983Term: Varicella zosterSystem Organ Class: 10021881 - Infections and infestationsMedDRA version: 18.1Level: PTClassification code 10046980Term: VaricellaSystem Organ Class: 10021881 - Infections and infestationsMedDRA version: 18.0Level: LLTClassification code 10050331Term: Varicella-like rashSystem Organ Class: 100000004858MedDRA version: 18.0Level: LLTClassification code 10063144Term: Varicella zoster virus serology positiveSystem Organ Class: 100000004848EUCTR2013-003535-30-EEGlaxoSmithKline Biologicals1,220